Prosecution Insights
Last updated: October 02, 2026

Examiner: GONZALES, JOSEPHINE MARIA

Tech Center 1600 • Art Units: 1631 1638

This examiner grants 27% of resolved cases

Analysis

Josephine Maria Gonzales examines cases in Tech Center 1600 and Art Unit 1631. She has 63 resolved cases. The allowance rate is 27.0 percent. This metric reflects the proportion of applications that reach a final grant in this docket, indicating the challenges applicants may face during the examination process.

The interview lift is 38.1 percent. This figure suggests that conducting an interview increases the probability of success compared to the 27.0 percent baseline. Direct communication may help resolve technical issues and move cases toward an allowance, as supported by the 63 resolved cases recorded in this docket.

The median time to allowance is 1505 days. This duration indicates the length of the prosecution process for successful cases. With 63 resolved cases, these figures offer a perspective on the hurdles and strategic opportunities in this docket, highlighting the value of interviews and providing a reliable basis for applicant strategy and expectation management.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

26.6%
Allow Rate
-33.4% vs TC avg
117
Total Applications
+38.4%
Interview Lift
1511
Avg Prosecution Days
Based on 64 resolved cases, 2023–2026

Rejection Statute Breakdown

5.5%
§101 Eligibility
16.6%
§102 Novelty
42.5%
§103 Obviousness
23.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18451617 GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS Non-Final OA WISCONSIN ALUMNI RESEARCH FOUNDATION
17764892 METHOD OF TREATING ARTERIOVENOUS MALFORMATIONS BY TARGETING THE EPHRIN PATHWAY Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17785145 EVALUATION METHOD OF DIFFERENTIATION STATE OF CELLS, AND CELL CULTURE SYSTEM Final Rejection HITACHI HIGH-TECH CORPORATION
17996541 GENETICALLY-MODIFIED CELL LINE FOR NK CELL ACTIVATION AND AMPLIFICATION, AND USE THEREOF Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
16981800 Detection of Interaction Between an Assay Substance and Blood or Blood Components for Immune Status Evaluation and Immune-Related Disease Detection and Diagnosis Non-Final OA UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
17043888 METHODS FOR IN VITRO EXPANSION OF ADULT TISSUE STEM CELLS Non-Final OA CEDARS-SINAI MEDICAL CENTER
16984241 METHOD FOR PRODUCING TAU-RELATED DISEASE MODEL Final Rejection Keio University
18556761 BIRDS FOR PRODUCING FEMALE HATCHLING AND METHODS OF PRODUCING SAME Non-Final OA B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University
18945866 COMPOSITION FOR PROMOTING PRODUCTION OF STEM CELL-DERIVED EXOSOMES AND INCREASING STEMNESS Non-Final OA BREXOGEN INC.
18267996 CELL CULTURE SYSTEMS, METHODS AND USES THEREOF Non-Final OA ACADEMIA SINICA
17010778 BROWN FAT CELLS AND METHOD FOR PREPARING SAME Non-Final OA Kyoto Prefectural Public University Corporation
17639800 NOVEL METHODS FOR REARING AND CONTROLLED RELEASE OF PREDATORY MITES Final Rejection Bio-Bee SDE Eliyahu Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month